The authors determined the association between metabolic syndrome in early pregnancy (mean, 11.96 weeks) and the risk of preterm birth in the mother-child cohort study (''Rhea'' Study) in Crete, Greece, 2007Greece, -2009. Maternal fasting serum samples were collected, and blood pressure was measured at the time of the first major ultrasound examination (n ¼ 625). Multivariable log-binomial regression models were used. Women with metabolic syndrome were at high risk for preterm birth (relative risk (RR) ¼ 2.93, 95% confidence interval (CI): 1.53, 5.58), with the highest risk observed for medically indicated preterm births (RR ¼ 5.13, 95% CI: 1.97, 13.38). Among the components of metabolic syndrome, the most significant risk factor was hypertension (RR ¼ 2.32, 95% CI: 1.28, 4.20). An elevation of 10 mm Hg in diastolic blood pressure increased the relative risk for preterm birth by 29% (RR ¼ 1.29, 95% CI: 1.08, 1.53), while a per unit increase in the low density lipoprotein/high density lipoprotein cholesterol ratio increased this risk by 19% (RR ¼ 1.19, 95% CI: 1.02, 1.39). Fetal weight growth restriction was associated with elevated levels of insulin (RR ¼ 1.14, 95% CI: 1.08, 1.20) and diastolic blood pressure (RR ¼ 1.27, 95% CI: 1.00, 1.61) in early pregnancy. These findings suggest that women with metabolic syndrome in early pregnancy had higher risk for preterm birth.
The metabolic syndrome is described as a cluster of metabolic abnormalities that appear to directly promote the development of atherosclerotic cardiovascular disease and are characterized by chronic low-grade systemic inflammation (1) (2) (3) . It is associated with the rising incidence of obesity in developed countries and is reaching epidemic proportions affecting between 24% and 34% of the US population (4) and up to 36% of Europeans aged 40-55 years (5) . In a recent study in Greece, the prevalence of metabolic syndrome was 25% in adult men and 15% in women according to the National Cholesterol Education Program, Adult Treatment Panel III, definition (6) . Metabolic syndrome is not a universally accepted entity and, although certain cardiovascular risk factors undoubtedly occur together more often than expected by chance, the underlying pathophysiology of the syndrome is unclear (7) .
A substantial body of epidemiologic evidence suggests that a poor in utero environment elicited by maternal dietary or placental insufficiency may ''program'' susceptibility in the fetus to later development of cardiovascular and metabolic disease. Moreover, epidemiologic studies suggest that women who deliver preterm (8, 9) or low-birth-weight infants (10, 11) have a higher risk later in life for cardiovascular disease. The metabolic profile of pregnant women who give birth to preterm or fetal growth-restricted neonates is not well investigated. A plausible hypothesis is that pregnant women with characteristics of metabolic syndrome give birth to preterm or fetal growth-restricted neonates that will later develop metabolic syndrome as children or young adults.
Previous studies have reported associations between prepregnancy obesity (12) (13) (14) , chronic hypertension (15) (16) (17) , dyslipidemia, and inflammation in early pregnancy (18, 19) and high risk of preterm birth and intrauterine growth restriction. There are no studies, however, on the association between maternal metabolic syndrome in early pregnancy examined as a whole phenotype with birth outcomes.
The objective of this study was to determine the association between metabolic syndrome characteristics in early pregnancy and the risk for delivery of a singleton preterm or fetal weight growth-restricted neonate.
MATERIALS AND METHODS
The mother-child cohort in Crete (Rhea Study)
The mother-child ''Rhea'' Study in Crete, Greece, is a prospective cohort examining a population sample of pregnant women and their children, at the prefecture of Heraklion. Pregnant women (Greek and immigrants) residents that became pregnant during 1 year starting in February 2007 have been contacted and asked to participate in the study. The first contact was made before 15 weeks' gestation, at the time of the first major ultrasound examination. Participants were invited to provide blood and urine samples and to participate in a face-to-face interview. Women were then contacted at the sixth month of pregnancy, at birth, and 1 month after birth, and they are currently contacted at 6 months and 2 years after birth. Face-to-face structured questionnaires, together with self-administered questionnaires and medical records, were used to obtain information on several factors including maternal age, education, height, prepregnancy weight, weight at blood collection, reproductive and medical histories, lifestyle (tobacco smoking and environmental tobacco smoke, consumption of medicaments, physical activity, and so on), and hours since last meal at blood collection. The study was approved by the corresponding ethical committees, and all participants provided written, informed consent.
During the study period, 1,765 eligible women were approached, 1,610 (91%) agreed to participate, and 1,317 (82%) were followed up until delivery. Only singleton pregnancies were included in this analysis (n ¼ 1,281). A total of 833 participants provided blood samples and, of them, 730 provided fasting blood samples. Women who experienced spontaneous or induced abortions (n ¼ 51) or gave birth to stillborn infants (n ¼ 2) were excluded as were those women with incomplete diagnostic information (n ¼ 39) for any of the following reasons: person moved, person delivered elsewhere, and/or medical records were missing. We also excluded 13 women with preeclampsia (8 in this and 5 in previous pregnancies), because this condition is associated with a higher probability of induced preterm birth. Hence, a cohort of 625 women was available for this analysis.
Biochemical analyses
Maternal fasting serum samples were collected at the first prenatal visit at or before 15 weeks' gestation (mean, 11.96 weeks; standard deviation, 1.49) in 10-mL vacutainer tubes, centrifuged, and then stored in aliquots at À80°C until assayed.
Plasma triglycerides, total cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol, and glucose concentrations were determined by using standard enzymatic procedures on an automatic analyzer (AU5400 high-volume chemistry analyzer; Olympus America, Inc., Melville, New York). The inter-and intraassay coefficients of variation for all parameters were less than 5%. The insulin concentration was determined by an IMMULITE 2000 immunoassay system (Siemens Healthcare Diagnostics, Inc., Deerfield, Illinois). The inter-and intraassay coefficients of variation were less than 9%. Insulin sensitivity was calculated by a homeostasis model assessment approach (glucose (mg/dl) 3 insulin (mU/ mL/405)) (20) . All analyses were performed without knowledge of birth outcomes.
Maternal anthropometry
Height, measured at the first prenatal visit, and prepregnancy weight, as reported at the first major ultrasound visit, were used to calculate the prepregnant body mass index (weight (kg)/height (m) 2 ).
Maternal blood pressure
Systolic and diastolic blood pressures were measured at the first major ultrasound visit at or before 15 weeks' gestation. Measurements were taken by using an electronic blood pressure monitor after 10 minutes of rest in a sitting position. Appropriate size cuffs were used with cuff width 40% of the mid-arm circumference. All readings were replicated 3 times in the right arm for each woman. The mean value obtained from the second and third readings was used in the analysis.
Definition of metabolic syndrome in early pregnancy
All participants were classified as having metabolic syndrome or not, according to the definitions provided by the recent National Cholesterol Education Program, Adult Treatment Panel III, criteria (1), with some considerations taken into account to adapt to our study population of pregnant women. Abdominal circumference was not considered as a criterion of obesity, although obesity was defined as a body mass index higher than 30 kg/m 2 prepregnancy. In particular, the metabolic syndrome was diagnosed if 3 or more of the following risk factors were present: a prepregnancy body mass index of >30 kg/m 2 ; a triglyceride level of !150 mg/dL; a HDL cholesterol level of <50 mg/dL; a fasting glucose level of !100 mg/dL, and a blood pressure level of !130/!85 mm Hg.
Preterm birth and fetal growth restriction
Preterm birth. The main outcome of interest was preterm birth at less than 37 weeks among singleton gestations. A spontaneous delivery was defined as a vaginal birth or a birth in which the woman was documented as having been in labor at the time of delivery but the labor was not documented as having been induced and was therefore presumed to be spontaneous. A medically indicated delivery was defined as one that required either an induction of labor or prelabor cesarean or both (21) . Gestational age was based on the interval between the last menstrual period and the date of delivery of the baby for 84% of the subjects. When the menstrual estimate of gestational age was inconsistent by 7 or more days with the ultrasound measurement taken in the first trimester of pregnancy (n ¼ 231, 15.8%), a quadratic regression formula describing the relation between crownrump length and gestational age was used instead (22) .
Fetal weight growth restriction and excess after accounting for genetic growth potential. A customized definition of impaired growth for the newborns of this study was developed taking into account their constitutional characteristics (23, 24) . The maternal and newborn characteristics considered a priori were as follows: gestational age (in weeks), maternal and paternal height (in centimeters), and age (in years); maternal prepregnancy weight (in kilograms), primiparous mother, and infant's sex. Gestational age and infant's sex were considered as possible modifiers. A multivariable fractional polynomial linear regression model was used to predict birth weight, allowing polynomial terms for continuous variables in the linear regression models (24).
The final model was obtained from a backward strategy retaining the variables with P < 0.05 and interaction terms with P < 0.1. Up to second-degree polynomial terms were considered for all continuous variables with powers chosen from the set (i.e., À2, À1, À½, 0, ½, 1, 2, 3). The model with the minimum deviance was retained. The final model included the following as covariates: gestational age (GA), infant's sex (male), maternal (MH) and paternal (PH) height, prepregnancy weight (MW), and the interaction of gestational age with maternal weight (MW 3 GA). The expected birth weight (BW) was predicted from a regression model explaining 32% of birth-weight variance from the equation:
BW ¼ 96:48ðGAÀ38:44Þþ150 male À32:94ðMWÀ64:59Þ þ 3;083:8 ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi ðMW3GA=1;000Þ À 1:58 p þ 7:92ðMH À163:5Þ þ 4:2ðPH À 177:08Þ þ 3;136:0:
We defined a neonate with fetal weight growth restriction if his/her actual birth weight fell below the 10th percentile of the predicted birth weight distribution. Potential confounders included characteristics that have an established or potential association with preterm birth, fetal growth restriction, and metabolic syndrome, including the following: maternal age at delivery; education (low level: 6 years of school, medium level: 12 years of school, high level: university or technical college degree); smoking during pregnancy (yes/no); marital status (single/ married-engaged); family history of hypertension (yes/no); family history of diabetes (yes/no); Greek origin (yes/no); parity; and physical activity during pregnancy (yes/no).
Statistical analysis
Data analysis was performed by using STATA, version 10.0, statistical software (StataCorp LP, College Station, Texas). The primary outcome variables of interest were preterm birth and fetal weight growth restriction. The primary exposure of interest was maternal metabolic syndrome and its components in early pregnancy. Bivariate associations between dependent and independent variables were studied by using Pearson's chi-square test for categorical variables or Student's t test for continuous ones. The Fisher exact test was used when less than 5 subjects were expected in a cell. The possibility of nonlinear associations was assessed by using generalized additive models. According to these models, the only nonlinear associations were found for systolic blood pressure and HDL cholesterol; therefore, these variables were additionally treated as categorical variables.
Multivariable log-binomial regression models were further performed to examine the association between metabolic syndrome in early pregnancy and the outcomes of interest after adjustment for confounders. Potential confounders related to the outcomes of interest in the bivariate models with P < 0.2 were included in the multivariable models. Relative risks and 95% confidence intervals were computed to estimate the degree of association. To account for the possibility of residual confounding, the remaining demographic, lifestyle, and pregnancy characteristics that were available in this data set were then sequentially forced into the parsimonious models to ensure that the estimates associated with metabolic syndrome in early pregnancy remained unchanged. Effect modification was evaluated by using the likelihood ratio test (a ¼ 0.10). All hypothesis testing was conducted assuming a 0.05 significance level and a 2-sided alternative hypothesis.
RESULTS
Complete information was available for all main model variables for 625 pregnant women. The demographic characteristics of pregnant women included and those not included in this analysis are shown in Table 1 . There were no major differences between the 2 groups. The prevalence of metabolic syndrome in early pregnancy was 3.5%. Women with metabolic syndrome were more likely to be less educated and to smoke more during pregnancy (Table 1) . Table 2 presents the distribution of the components of metabolic syndrome in women with and without the syndrome in early pregnancy. As expected, women with metabolic syndrome had a very high prevalence of the individual components of the syndrome compared with those without metabolic syndrome. Insulin resistance, measured by homeostasis model assessment, was also elevated in women with metabolic syndrome in early pregnancy (P ¼ 0.005). Table 3 presents the associations between metabolic syndrome in early pregnancy, as well as its components, and preterm birth and fetal growth restriction. Women with metabolic syndrome were at high risk for preterm birth (relative risk (RR) ¼ 2.93, 95% confidence interval (CI): 1.53, 5.58), whereas among the components of metabolic syndrome, the most significant risk factor was hypertension (RR ¼ 2.32, 95% CI: 1.28, 4.20) after adjustment for maternal age, maternal education, and maternal smoking during pregnancy. The risk for medically indicated preterm deliveries increased in women with metabolic syndrome (RR ¼ 5.13, 95% CI: 1.97, 13.38), and the most significant risk factor was hypertension (RR ¼ 3.92, 95% CI: 1.57, 9.77). The risk for spontaneous preterm deliveries was also elevated but not significantly associated with metabolic syndrome or its components in early pregnancy (Table 3) .
In an alternative analysis, all neonates with fetal weight growth restriction were excluded to evaluate whether results were related to preterm birth or to comorbid disorders and, specifically, fetal growth restriction ( Table 3 ). The relative risk for women with metabolic syndrome increased from 2.93 to 3.79 (95% CI: 2.07, 6.95) and for women with hypertension from 2.32 to 2.64 (95% CI: 1.42, 4.90) after adjustment for maternal age, maternal education, and maternal smoking during pregnancy.
The associations of different clinical parameters linked with metabolic syndrome were evaluated separately (Table  4 ). An elevation of 10 mm Hg in diastolic blood pressure increased the relative risk for all preterm births by 29% (RR ¼ 1.29, 95% CI: 1.08, 1.53) and for medically indicated preterm births by 67% (RR ¼ 1.67, 95% CI: 1.12, 2.49). An elevation of 40 mg/dL in total cholesterol increased the relative risk for all preterm births by 24% (RR ¼ 1.24, 95% CI: 0.99, 1.56) and for medically indicated preterm births by 52% (RR ¼ 1.52, 95% CI: 1.04, 2.24), while a per unit increase in the LDL/HDL cholesterol ratio increased the relative risk for preterm birth by 19% (RR ¼ 1.19, 95% CI: 1.02, 1.39) after adjustment for maternal age, maternal education, and maternal smoking during pregnancy. No significant associations were found for women in the highest tertile of systolic blood pressure (RR ¼ 1.19, 95% CI: 0.69, 2.08) and HDL cholesterol (RR ¼ 1.00, 95% CI: 0.60, 1.67). After removing fetal weight growth restriction neonates, we obtained similar results ( Table 4) .
The association of pregestational hypertension or diabetes with preterm births was examined by excluding 18 women with these diagnoses. After their exclusion, the relative risks for metabolic syndrome remained statistically significant and very similar to the values reported in Tables  3 and 4 (refer also to Web Tables 1 and 2) . (This information is described in 2 supplementary tables posted on the Journal's website (http://aje.oxfordjournals.org/).) Fetal weight growth restriction was associated with elevated levels of insulin in early pregnancy (RR ¼ 1.14, 95% CI: 1.08, 1.20) and elevated levels of diastolic blood pressure (RR ¼ 1.27, 95% CI: 1.00, 1.61) ( Table 4) .
DISCUSSION
The present study provides novel evidence that women with singleton pregnancies without preeclampsia who gave birth to preterm infants had evidence of metabolic syndrome before 15 weeks of gestation compared with women with term births. Metabolic syndrome is not a universally accepted entity and, although certain cardiovascular risk factors undoubtedly occur together more often than expected by chance, the underlying pathophysiology of the syndrome is unclear (7) . However, the main objective of our study was not to evaluate the pathophysiology of metabolic syndrome, but rather to evaluate independent and combined components of what is postulated to be a syndrome. This is the first time that metabolic syndrome in early pregnancy has been evaluated in relation to reproductive outcomes, and some questions could be raised regarding the appropriateness of its use in pregnancy. The collection of blood early in pregnancy (mean gestational age, 12 weeks) probably enabled the detection of disordered plasma lipid, glucose, and insulin concentrations before the pregnancy-related changes of these parameters. A recent study has shown that the value distributions and the relative percentage of women with undesirable or abnormal values according to current National Cholesterol Education Program goals were comparable between controls and women in the first trimester (25) . However, it still remains unclear whether the elevations in lipids that were detected early in pregnancy existed prior to conception or were an early aberration associated with implantation (26) . In the present study, women with normal weight prepregnancy put on more weight at 12 weeks of gestation (3.8% of the initial weight) compared with overweight (2.7%) or obese (2.0%) women. Therefore, we decided not to use body mass index assessed in the first trimester of gestation, as it may introduce changes due to the pregnancy.
The strengths of the present study include the populationbased, prospective design and detailed and valid data for metabolic syndrome components. Unlike previous epidemiologic studies, blood pressure, lipid, glucose, and insulin concentrations in early pregnancy were precisely measured and not self-reported. Moreover, fasting serum samples were available that are a rather complicated goal for a cohort involving pregnant women. Several factors that might be related to metabolic syndrome in early pregnancy, preterm birth, and fetal growth restriction were evaluated as potential confounders. As preterm birth is a heterogeneous rather than a homogeneous entity, we had the opportunity to distinguish between spontaneous and medically indicated preterm births. Unfortunately, we were not able to distinguish between preterm (<37 weeks) and very preterm (<34 weeks) births because of small numbers. The exclusion of women who gave birth to twins or had been diagnosed with preeclampsia in the current pregnancy, as well as adjustment for several sociodemographic variables, reduced the likelihood of confounding. To evaluate the possibility of introducing confounding by causes of preeclampsia other than metabolic syndrome, we did additional analyses including pregnancies complicated by preeclampsia in the present or previous pregnancies, and the results remained essentially the same as those from the original analysis (data not shown). In this study, the highest risk associated with metabolic syndrome was observed for medically indicated preterm births. Recent studies have shown that much of the increase in the singleton preterm birth rate was driven by a concurrent temporal increase in medically indicated preterm birth (27, 28) . Maternal and fetal conditions that trigger the need for medical intervention (such as placental abruption, placenta previa, fetal distress, gestational diabetes, preeclampsia, renal disease, and fetal growth restriction) are initiated by multiple mechanisms including inflammation or infection, uteroplacental ischemia, stress, and other immunologically mediated processes (29) . Because many of the components of metabolic syndrome result in increased low-grade systemic inflammation (2, 3, 30) , an increasing stimulation of the inflammation pathway conferred from the mother with metabolic aberrations to the fetus might explain the increased risk of medically indicated preterm births in women with metabolic syndrome in early pregnancy.
Pregnant women with hypertension in early pregnancy had an increased risk for preterm birth, even after the exclusion of fetal weight growth restriction neonates. These results are consistent with those from the few other studies that evaluated the association of chronic hypertension with preterm birth and intrauterine growth restriction (15) (16) (17) . Women with hypertension show a specific defect of endothelialdependent vascular function compared with women with a history of a healthy pregnancy, independently of maternal obesity, and metabolic disturbances associated with insulin resistance or dyslipidemia (31) .
A high LDL/HDL cholesterol ratio was significantly associated with increased risk for preterm birth, high levels of total cholesterol were associated with increased risk for spontaneous preterm birth, while low levels of HDL cholesterol were associated with increased risk for fetal weight growth restriction. These findings are consistent with those of the few other studies that examined the same hypothesis (18, 19, 32) . Maternal hyperlipidemia could increase the oxidative stress in the fetus resulting not only in damage of the vessel wall, but also in the disruption of normal placentation.
The identification of newborns who present an abnormality of intrauterine growth remains problematic. Customized birth weight percentiles were designed to better differentiate between infants who are small because their in utero growth has been restricted and infants who are small but have reached their individual growth potential (33) . The normative values in customized percentiles at younger gestational ages are based on the distribution of the best estimate of intrauterine weights, whereas conventional birth-weight charts are based on the weights of livebirths. A recent study has shown that a noncustomized but intrauterine-based standard has a similar ability to predict risk for stillbirth and early neonatal mortality as a customized birth-weight standard (34) . In the present study, we did not have the opportunity to perform intrauterine-based growth charts; therefore, we used the new term fetal growth restriction to define an infant who has not achieved its genetic growth potential in utero on the basis of customized birth-weight percentiles (24) . In summary, these results suggest that women with metabolic syndrome in early pregnancy had higher risk for preterm birth. The complex underlying processes that explain these findings require additional study. Further follow-up of this cohort will allow determining if metabolic syndrome in early pregnancy has, in addition, an effect on cardiovascular risk in childhood and also long-term maternal health risks.
